Previous studies have implicated ERO1α in a range of different cancer types, with current evidence suggesting potential roles in cancer cell invasion of healthy tissues, acquisition of chemoresistant properties, and promotion of angiogenesis [39]. The gene discussed is ERO1A; the disease is cancer.